« Back
Home /
Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)

Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)

Item no.	MAA124Hu22-20ug
Manufacturer	Cloud-Clone
Amount	20 ug
Quantity options	100 ul 1 ml 200 ul 20 ug 20 ul 500 ul
Category	Oncology Neuroscience Neuroinflammation Infectious Diseases Viral Infections Coronavirus (COVID-19) Antibodies By Cell Type Carcinoma Cell Biology Cell Culture Cytokines Mesothelioma Immunohistochemistry Western Blot ELISA Immunocytochemistry Primary Antibodies By Organ Colorectal Cancer
Type	Antibody Monoclonal
Format	Liquid
Applications	WB, IP, IHC, ICC
Clone	A1
Specific against	Human (Homo sapiens)
Host	Mouse
Citations	Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE1 axis
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	TGF-B1; CED; DPD1; LAP; Camurati-Engelmann Disease; Latency-associated peptide
Available
Manufacturer - Category	Primary Ab
Research Area	Cytokine, Tumor immunity, Infection immunity,
Buffer Formulation	0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Immunogen	RPA124Hu01-Recombinant Transforming Growth Factor Beta 1 (TGFb1)
Usage	Western blotting: 0.01-3µg/mL; < br/> Immunohistochemistry: 5-20µg/mL; < br/> Immunocytochemistry: 5-20µg/mL; < br/> Optimal working dilutions must be determined by end user.
Purification	Protein A + Protein G affinity chromatography

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.